Invention Grant
US08357720B2 Treatment or prevention of cancer and precancerous disorders 失效
治疗或预防癌症和癌前期疾病

Treatment or prevention of cancer and precancerous disorders
Abstract:
The NSAID, sulindac and/or its metabolites and derivatives, in combination with an agent that generates or induces reactive oxygen species (ROS), significantly enhances the killing of abnormal cells but does not affect normal cells. This effect occurs at concentrations of each compound that individually have little or no activity directed against the abnormal cells.
Public/Granted literature
Information query
Patent Agency Ranking
0/0